ClinicalTrials.Veeva

Menu

Pancreas Cancer Surveillance Using an Abbreviated MRI

Seoul National University logo

Seoul National University

Status

Active, not recruiting

Conditions

Pancreas Cancer

Treatments

Diagnostic Test: Conventional follow-up
Diagnostic Test: Abbreviated PB MRI
Genetic: Gene mutation test

Study type

Interventional

Funder types

Other

Identifiers

NCT04592393
SNUH-2020-2950

Details and patient eligibility

About

This study aims to establish a prospective cohort of developing pancreas cancer and surveillance MRI protocol. With the focused surveillance protocol, we perform surveillance for pancreas cancer for five years to estimate the risk of pancreas cancer and the clinical feasibility of the surveillance MRI.

Enrollment

200 patients

Sex

All

Ages

50 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • On follow-up due to first degree-family history of PAC
  • Or on follow-up for BD-IPMN (>= 2 cm) or main-duct type IPMN (> 5 mm)
  • And signed informed consent

Exclusion criteria

  • Contra-indication of performing MRI
  • Not satisfying the selection criteria.
  • Previously diagnosed with pancreatic malignancy
  • Pregnancy or planning pregnancy

Trial design

Primary purpose

Screening

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

200 participants in 1 patient group

Abbreviated PB MRI
Experimental group
Description:
Short and Focused non-contrast MRI for surveillance
Treatment:
Genetic: Gene mutation test
Diagnostic Test: Conventional follow-up
Diagnostic Test: Abbreviated PB MRI

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems